According to CoherentMI, The neuroendocrine prostate cancer market is estimated to be valued at USD 1034.5 Mn in 2025 and is expected to reach USD 1694.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. https://www.zupyak.com/p/4558119/t/neuroendocrine-prostate-cancer-market-booms-on-targeted-therapies